Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H24N2O |
| Molecular Weight | 272.3853 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1=NC(OCCN(C)C)=C2C=CC=CC2=C1
InChI
InChIKey=XNMYNYSCEJBRPZ-UHFFFAOYSA-N
InChI=1S/C17H24N2O/c1-4-5-9-15-13-14-8-6-7-10-16(14)17(18-15)20-12-11-19(2)3/h6-8,10,13H,4-5,9,11-12H2,1-3H3
| Molecular Formula | C17H24N2O |
| Molecular Weight | 272.3853 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1907589 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11714893 |
|||
Target ID: CHEMBL1907591 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11714893 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
To the skin as a 0.5% oinment or lotion 2 to 4 times per day.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2169310
Various local anesthetics enhanced the incorporation of [3H]inositol into phosphoinositides in guinea pig cerebral cortical synaptoneurosomes. Dibucaine, QX-572 and dimethisoquin showed maximum stimulation at 100 microM. There was no correlation between local anesthetic activity, estimated by inhibition of the 22Na+ flux elicited by the sodium channel activator batrachotoxin, and the potency for stimulation of inositol incorporation.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:25:38 GMT 2025
by
admin
on
Wed Apr 02 08:25:38 GMT 2025
|
| Record UNII |
772EN3BH6I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
||
|
WHO-VATC |
QD04AB05
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
||
|
WHO-ATC |
D04AB05
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m1118
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | Merck Index | ||
|
772EN3BH6I
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
DTXSID8048525
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
C009146
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
86-80-6
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
SUB10218MIG
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
QUINISOCAINE
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
367
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
39695
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
DB13683
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
CHEMBL127643
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
C72169
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
6857
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
3153
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
201-700-0
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY | |||
|
100000129314
Created by
admin on Wed Apr 02 08:25:38 GMT 2025 , Edited by admin on Wed Apr 02 08:25:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |